Premium
ADC Therapeutics SA (ADCT)
NYSE
Hot Features
Inscrivez-vous pour interagir sur nos forums actifs pour discuter avec des investisseurs aux idées similaires.
ADC Therapeutics SA is a commercial-stage oncology-focused biotechnology company. It is involved in the development of antibody-drug conjugates for patients suffering from hematological malignancies and solid tumors. The company's product candidate includes ZYNLONTA, camidanlumab tesirine, ADCT-602,... ADC Therapeutics SA is a commercial-stage oncology-focused biotechnology company. It is involved in the development of antibody-drug conjugates for patients suffering from hematological malignancies and solid tumors. The company's product candidate includes ZYNLONTA, camidanlumab tesirine, ADCT-602, ADCT-601, ADCT-901, ADCT-701 and ADCT-212. Show more
ADC Therapeutics Announces Positive Initial Data from LOTIS-7 Clinical Trial Evaluating ZYNLONTA® in Combination with Bispecific Antibody in Patients with Relapsed/Refractory Diffuse Large B-cell...
ADC Therapeutics Announces The Lancet Haematology Publication of Data from Investigator-Initiated Trial Evaluating ZYNLONTA® in Combination with Rituximab to Treat Relapsed/Refractory Follicular...
ADC Therapeutics to Provide Initial Data Update on LOTIS-7 Clinical Trial PR Newswire LAUSANNE, Switzerland, Dec. 6, 2024 Company to host corporate update webcast to share results on December 11...
ADC Therapeutics Makes Grants to New Employees Under Inducement Plan PR Newswire LAUSANNE, Switzerland, Dec. 2, 2024 LAUSANNE, Switzerland, Dec. 2, 2024 /PRNewswire/ -- ADC Therapeutics SA (NYSE:...
ADC Therapeutics Reports Third Quarter and Year-to-Date 2024 Financial Results and Provides Operational Update PR Newswire LAUSANNE, Switzerland, Nov. 7, 2024 LOTIS-5 full enrollment and LOTIS-7...
| Période | Variation | Variation % | Ouver. | Haut | Bas | Moyenne Vol. Quot. | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | 0.05 | 2.5 | 2 | 2.21 | 1.8 | 1406509 | 2.01025073 | CS |
| 4 | 0.13 | 6.77083333333 | 1.92 | 3.49 | 1.8 | 1713870 | 2.58402186 | CS |
| 12 | -1.02 | -33.2247557003 | 3.07 | 3.49 | 1.8 | 808274 | 2.67311413 | CS |
| 26 | -0.61 | -22.9323308271 | 2.66 | 4.13 | 1.8 | 619600 | 2.87027072 | CS |
| 52 | 0.61 | 42.3611111111 | 1.44 | 6.04 | 1.18 | 666636 | 3.29470695 | CS |
| 156 | -17.53 | -89.5301327886 | 19.58 | 22.52 | 0.359908 | 509889 | 3.78625242 | CS |
| 260 | -27.95 | -93.1666666667 | 30 | 56.5899 | 0.359908 | 418868 | 9.16396947 | CS |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales
